In the present study, all CML patients were in the chronic phase thus, so the p53 gene was non-mutated given the fact that only 20% of CML patients at the blast crisis phase and very little at the chronic phase exhibit mutated p53. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.